#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Clostridium difficile infection

Recruiting

Investigational

A study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:AZD5148

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drugNo placebo

Study of Revumenib, Cytarabine, and Fludarabine in Children with Relapsed or Refractory Acute Myeloid Leukemia

Registered drugNo placebo

Sweden

Participants:0–17 years · 18–64 years
Substances:Cytarabine

Contact Research Centre

Gastric cancer+2

Recruiting

InvestigationalNo placebo

A study to evaluate the use of FAPI-46 (68Ga) imaging to detect peritoneal cancer spread in patients with colorectal, gastric, ovarian, or pancreatic cancer

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Contact Research Centre

Metabolic dysfunction-associated liver disease

Recruiting

Investigational

N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Ly3437943 Sodium

Contact Research Centre

Systemic lupus erythematosus

Recruiting

Investigational

Evaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Litifilimab

Contact Research Centre

Amyotrophic lateral sclerosis

Recruiting

Investigational

A Study Testing the Safety of LTX-002 Sodium Given into the Spinal Canal in Adults with Amyotrophic Lateral Sclerosis

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:LTX-002 SODIUM

Contact Research Centre

Cardiac failure+1

Recruiting

InvestigationalNo placebo

A study of finerenone with standard treatment for children and young adults from birth to 18 years with heart failure and left ventricular systolic dysfunction

InvestigationalNo placebo

Sweden

Participants:0–17 years · 18–64 years
Substances:Finerenone

Contact Research Centre

Cardiac failure+1

Recruiting

Investigational

A study of finerenone added to standard treatment in children aged 6 months to under 18 years with heart failure and reduced left heart pumping function

Investigational

Sweden

Participants:0–17 years
Substances:Finerenone

Contact Research Centre

Adrenogenital syndrome

Recruiting

Investigational

A Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:ATUMELNANT

Contact Research Centre

Short-bowel syndrome

Recruiting

Investigational

Study of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Glepaglutide

Contact Research Centre

Neoplasm malignant

Recruiting

Registered drugNo placebo

A Study of Sodium Selenite Followed by Chemotherapy in Patients with Advanced Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:SODIUM SELENITE PENTAHYDRATE

Contact Research Centre

Alpha-1 antitrypsin deficiency

Recruiting

InvestigationalNo placebo

A study comparing under-the-skin and into-the-vein alpha1-proteinase inhibitor treatment in patients with alpha1-antitrypsin deficiency

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Human Alpha1-Proteinase Inhibitor

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.